Patents by Inventor Cheng-Po Huang
Cheng-Po Huang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11945885Abstract: A vinyl-containing copolymer is copolymerized from (a) first compound, (b) second compound, and (c) third compound. (a) First compound is an aromatic compound having a single vinyl group. (b) Second compound is polybutadiene or polybutadiene-styrene having side vinyl groups. (c) Third compound is an acrylate compound. The vinyl-containing copolymer includes 0.003 mol/g to 0.010 mol/g of benzene ring, 0.0005 mol/g to 0.008 mol/g of vinyl group, and 1.2*10?5 mol/g to 2.4*10?4 mol/g of ester group.Type: GrantFiled: December 29, 2022Date of Patent: April 2, 2024Assignee: INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTEInventors: Cheng-Po Kuo, Shin-Liang Kuo, Shu-Chuan Huang, Yan-Ting Jiang, Jian-Yi Hang, Wen-Sheng Chang
-
Publication number: 20210137945Abstract: Provided herein is a method for the treatment and/or prophylaxis of a cancer associated with galectin-1. The method includes administering to a subject a pharmaceutical composition that mainly composed of ganoderic acid S (GAS) and ganoderic acid T (GAT). The method further includes administering to the subject another anti-cancer agent before, together with, or after the administration of the present pharmaceutical composition, so as to synergistically suppress the growth of the cancer.Type: ApplicationFiled: November 13, 2019Publication date: May 13, 2021Applicant: TRINEO BIOTECHNOLOGY CO. LTDInventors: Teng-Hai CHEN, Mon-Tarng CHEN, Chien-Yuan WANG, Cheng-Po HUANG, Su-Yu CHEN, Yi-Hsiu LIN, Ssu-Chia WANG, Chih-Yuan LIAO
-
Patent number: 10357525Abstract: Disclosed herein is a novel use of a polysaccharide mixture for the treatment of hyperglycemia and/or disorders related thereto (e.g., diabetes mellitus). The polysaccharide mixture comprises about 30-50% (wt %) of ?(1?3) glucan and ?(1?6) glucan, and has a molecular weight of at least 500,000. The polysaccharide mixture may be administered to a subject suffering from hyperglycemia in a dose of about 1 to 1,000 mg/Kg to ameliorate or alleviate symptoms associated with hyperglycemia.Type: GrantFiled: May 31, 2017Date of Patent: July 23, 2019Assignee: TRINEO BIOTECHNOLOGY CO. LTDInventors: Cheng-Po Huang, Cheng-Chiu Tsao, Chao-hsuan Chang, Teng-Hai Chen, Li-Ming Huang, Chieh-Hung Lin
-
Publication number: 20180344784Abstract: Disclosed herein is a novel use of a polysaccharide mixture for the treatment of hyperglycemia and/or disorders related thereto (e.g., diabetes mellitus). The polysaccharide mixture comprises about 30-50% (wt %) of ?(1?3) glucan and ?(1?6) glucan, and has a molecular weight of at least 500,000. The polysaccharide mixture may be administered to a subject suffering from hyperglycemia in a dose of about 1 to 1,000 mg/Kg to ameliorate or alleviate symptoms associated with hyperglycemia.Type: ApplicationFiled: May 31, 2017Publication date: December 6, 2018Applicant: TRINEO BIOTECHNOLOGY CO. LTDInventors: Cheng-Po HUANG, Cheng-Chiu TSAO, Chao-hsuan CHANG, Teng-Hai CHEN, Li-Ming HUANG, Chieh-Hung LIN
-
Patent number: 9512168Abstract: Disclosed herein are compositions and methods for the treatment or prophylaxis of a subject having or susceptible to a kidney disease. The method includes the step of administering to the subject a compound of formula (I) in a dose of about 1 to 10 mg/Kg to improve the glomerular filtration rate (GFR) of the subject for at least 4 folds as compared to the GFR of the subject before treatment, The method further includes the step of administering to the subject an effective amount of lucidenic acid C (LAC), lucidenic acid N (LAN), lucidenic acid E2 (LAE2), lucidenic acid A (LAA), and lucidenic acid D2 (LAD2).Type: GrantFiled: June 9, 2014Date of Patent: December 6, 2016Inventors: Cheng-Po Huang, Teng-Hai Chen, Kuang Dee Chen, Chun-Tao Su
-
Publication number: 20150353595Abstract: Disclosed herein are compositions and methods for the treatment or prophylaxis of a subject having or susceptible to a kidney disease. The method includes the step of administering to the subject a compound of formula (I) in a dose of about 1 to 10 mg/Kg to improve the glomerular filtration rate (GFR) of the subject for at least 4 folds as compared to the GFR of the subject before treatment, The method further includes the step of administering to the subject an effective amount of lucidenic acid C (LAC), lucidenic acid N (LAN), lucidenic acid E2 (LAE2), lucidenic acid A (LAA), and lucidenic acid D2 (LAD2).Type: ApplicationFiled: June 9, 2014Publication date: December 10, 2015Applicant: Trineo Biotechnology Co. LTD.Inventors: Cheng-Po Huang, Teng-Hai Chen, Kuang Dee Chen, Chun-Tao Su
-
Patent number: 9198922Abstract: Disclosed herein is a composition that includes a novel combination of triterpenoids for the treatment or prophylaxis of a cancer. The triterpenoids includes at least ganoderic acid S (GAS), ganoderic acid T (GAT), ganoderic acid Me (GAMe), ganoderic acid R (GAR), and ganodermic acid S (GMAS). The composition is suitable for the treatment or prophylaxis of colon cancer, hepatic cancer, breast cancer, lung cancer or leukemia.Type: GrantFiled: May 28, 2013Date of Patent: December 1, 2015Assignee: Double Crane Biotechnology Co., Ltd.Inventors: Shwu-Bin Lin, Cheng-Po Huang, Teng-Hai Chen, Kuang-Dee Chen
-
Patent number: 9144590Abstract: Disclosed herein is the use of an extract from an Aster species for the preparation of a medicament for the treatment of opioid-induced constipation. The extract is extracted from fresh and/or dried roots and rhizomes of a Tatarian aster (Aster tartaricus) plant, in which the extraction uses water or 40-95% (v/v) ethanol as an extractant to obtain an extraction mixture. In some embodiments, the extraction mixture is then eluted with water followed by at least one eluent.Type: GrantFiled: December 23, 2011Date of Patent: September 29, 2015Assignee: Medical and Pharmaceutical Industry Technology and Development CenterInventors: Jui-Ching Chen, Che-Yi Lin, Chien-Chang Wu, Cheng-Po Huang, Yuan-Ling Ku, Yueh-Chu Chen, Yu-Hsuan Lin, Chih-Sheng Hung
-
Publication number: 20140357604Abstract: Disclosed herein is a composition that includes a novel combination of triterpenoids for the treatment or prophylaxis of a cancer. The triterpenoids includes at least ganoderic acid S (GAS), ganoderic acid T (GAT), ganoderic acid Me (GAMe), ganoderic acid R (GAR), and ganodermic acid S (GMAS). The composition is suitable for the treatment or prophylaxis of colon cancer, hepatic cancer, breast cancer, lung cancer or leukemia.Type: ApplicationFiled: May 28, 2013Publication date: December 4, 2014Inventors: Shwu-Bin Lin, Cheng-Po Huang, Teng-Hai Chen, Kuang-Dee Chen
-
Publication number: 20140294753Abstract: Novel Uses of a small molecule, ganodermic acid S (GMAS), are disclosed herein. The GMAS is useful as a lead compound for manufacturing a medicament or a pharmaceutical composition for treating cancer, including metastatic or drug-resistant cancer, in a patient.Type: ApplicationFiled: March 29, 2013Publication date: October 2, 2014Applicant: Double Crane Biotechnology Co. LTDInventors: Shwu-Bin LIN, Cheng-Po HUANG, Teng-Hai CHEN
-
Publication number: 20120164251Abstract: Disclosed herein is the use of an extract from an Aster species for the preparation of a medicament for the treatment of opioid-induced constipation. The extract is extracted from fresh and/or dried roots and rhizomes of a Tatarian aster (Aster tartaricus) plant, in which the extraction uses water or 40-95% (v/v) ethanol as an extractant to obtain an extraction mixture. In some embodiments, the extraction mixture is then eluted with water followed by at least one eluent.Type: ApplicationFiled: December 23, 2011Publication date: June 28, 2012Inventors: Jui-Ching CHEN, Che-Yi Lin, Chien-Chang Wu, Cheng-Po Huang, Yuan-Ling Ku, Yueh-Chu Chen, Yu-Hsuan Lin, Chih-Sheng Hung
-
Publication number: 20100014259Abstract: A modular circuit board structure for a large current area includes a circuit board having an electric conducting circuit and at least one large current area, and a conducting plate device having conducting plates installed onto the circuit board according to the shape of the large current area. When electronic components are inserted onto the circuit board by a surface mount technology, the conducting plates are attached onto the large current area to form a solder area portion on the conducting plates for allowing a large current to pass through, so as to provide a flexible combination function for the large current area of the circuit board and simplify the stamping molds of different shapes. The invention can avoid a waste of copper plates, assure the reliability, quality and safety of the circuit board, and enhance the cost effectiveness of the manufacture and the competitiveness of the product.Type: ApplicationFiled: July 15, 2008Publication date: January 21, 2010Applicant: ENERMAX TECHNOLOGY CORPORATIONInventor: Cheng Po Huang
-
Patent number: 7491095Abstract: A power supply socket device includes a circuit board and sockets. Each socket is a rectangular base, and the sockets are arranged linearly on the circuit board and have insert holes in the sockets. The insert holes are arranged in rows and columns with at least one row, and each row includes linearly arranged insert holes, and the number of insert holes in any row of each socket is greater than the number of insert holes of any column of each socket, such that the socket has a short socket side and a long socket side, and a latch lump is protruded from an appropriate position of the short socket side. The invention provides a quick, simple and convenient way of connecting a power supply and achieves the effects of simplifying the circuit board and improving the economic benefit of the manufacture and assembling and the competitiveness of the product.Type: GrantFiled: February 25, 2008Date of Patent: February 17, 2009Assignee: Enermax Technology CorporationInventor: Cheng-Po Huang